Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2022-07-18 Transaction in Own Shar…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 99% confidence The document is titled "Transactions in connection with share buy-back program" and details the execution of transactions under a previously announced share buy-back program, including the number of shares bought and the average price paid over several days. This activity directly relates to the company managing its own shares, which corresponds precisely to the definition of 'Transaction in Own Shares'. Therefore, the filing type code is POS.
2022-07-18 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a detailed transaction log of a share buyback program, listing specific volumes, prices, venues, and timestamps for trades executed by Genmab. This type of disclosure is a standard regulatory requirement for companies conducting share repurchases to provide transparency on their market activity. It falls under the category of 'Transaction in Own Shares'.
2022-07-18 English
Transactions in connection with share buy-back program
Transaction in Own Shares Classification · 100% confidence The document is a company announcement from Genmab A/S detailing specific transactions executed under a share buy-back program. It provides a table of shares repurchased over a specific period (July 11-15, 2022), the average price, and the total value, as well as the updated treasury share count. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2022-07-18 Danish
6-K
Foreign Filer Report
2022-07-11 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Major Shareholder Announcement" and details that Wellington Management Group LLP has increased its holding of shares in Genmab A/S, crossing a threshold (5.01%). This directly corresponds to the definition of a Major Shareholding Notification, which is categorized under the code MRQ (Major Shareholding Notification). The document is short and serves as an announcement of this change, not a comprehensive report.
2022-07-11 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 100% confidence The document is titled 'Major Shareholder Announcement' and explicitly states that Wellington Management Group LLP has increased its shareholding in Genmab A/S to over 5%. This is a standard regulatory disclosure regarding changes in significant share ownership, which aligns perfectly with the 'Major Shareholding Notification' (MRQ) category.
2022-07-11 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.